Press Releases
 
Systemic Lupus Erythematosus Analysis, Clinical Trials and Developments

United States, 8 December 2018 -- The study analyzed that the systemic lupus erythematosus pipeline comprises of 57 drug candidates in different stages of development.

Systemic lupus erythematosus is a type of lupus in which the immune system damages its own tissues. The disease affects many parts of the body including skin, joints, lungs, brain, blood vessels and kidneys. The systemic lupus erythematosus is caused by impaired immune system due to which the immune system attacks its own tissues and can cause widespread inflammation and tissue damage in the affected organs. Some of the common symptoms of systemic lupus erythematosus include oral ulcers, sun sensitivity, heart problems, kidney problems, psychosis, lung problems, arthritis, seizures, fevers, skin rashes, fatigue, swelling and pain in the joints. Systemic lupus erythematosus is being treated using a combination approach as number of organs are involved. Therefore, various combination therapies are being used to improve quality of life of the patients. Also, combining novel drugs against different organs as well as combination of drugs with biological and biochemical agents may further enhance the treatment quality.

Browse report sample at: https://www.psmarketresearch.com/market-analysis/systemic-lupus-erythematosus-pipeline-analysis/report-sample

Seattle Genetics, Inc. is using antibody-drug conjugate (ADC) technology platform for the development of Brentuximab vedotin for the treatment of systemic lupus erythematosus. The technology platform employs a monoclonal antibody specific for a tumor-associated antigen, plus synthetic cytotoxic (cell-killing) agents connected by stable linker systems designed to securely bind the cytotoxic agent to the antibody and then release the agent within the targeted cell.

Browse report at: https://www.psmarketresearch.com/market-analysis/systemic-lupus-erythematosus-pipeline-analysis

Some of the key players developing drugs for systemic lupus erythematosus include Anthera Pharmaceuticals, Inc., Genentech, Inc., Merck KGaA and others.

# # #


Submitted by Jacob, P&S Market Research on Saturday, 8 December 2018 at 12:57 AM
Category: Health Care & Medical
 
Related News

Cholera Vaccines Market Analysis and In-Depth Research
Tuesday, 11 Dec 2018

Amenorrhea Market Outlook to 2026 Scrutinized in New Research
Tuesday, 11 Dec 2018

Horseradish Peroxidase Market Outlook up to 2026
Tuesday, 11 Dec 2018

Calcium Phosphate Market Forecast By 2018–2026 With Top Industry Players
Tuesday, 11 Dec 2018

Picking a Family Dentist
Tuesday, 11 Dec 2018

Related Events

5th Winter Process Chemistry Conference And Exhibition, Manchester, UK
Tuesday, 11 Dec 2018

The FDA/CMS Summit
Tuesday, 11 Dec 2018

The 38th Annual Meeting of the Israeli Orthopaedic Association, Tel-Aviv
Wednesday, 12 Dec 2018

3rd New Product Planning Summit
Wednesday, 12 Dec 2018

Tumor Targeted Lymphocyte Summit 2018 | Boston, MA | December 12-13, 2018
Wednesday, 12 Dec 2018

Latest News

Jogi Gems with Passion for Natural Stands the Best Among the Wholesale Diamond Suppliers
Wednesday, 12 Dec 2018

Tamona.ae Dealing with Great Party Supplies Dubai Starts Great Christmas Sale with Attractive Deal
Wednesday, 12 Dec 2018

Excited News:6% off rs3 gold on RSorder as Xmas Meaningful Gift for you Till Dec.18
Wednesday, 12 Dec 2018

Biggest Surprise:6% off 07 runescape gold for OSRS Kebos Lowlands Release Till Dec.18
Wednesday, 12 Dec 2018

Ways to Obtain An Specialist In Family Dentistry
Wednesday, 12 Dec 2018

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2018
Today is Wednesday, 12 December 2018

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Palo Alto Networks: SKO ON THE ROAD: CCA
  • The FDA/CMS Summit
  • Palo Alto Networks: Cyber Tuesday - Cyber Range Level 1
  • 5th Winter Process Chemistry Conference And Exhibition, Manchester, UK
  • Palo Alto Networks: Ultimate Test Drive - Threat Prevention

  • Latest Jobs
    Sorry, there are currently no entries posted here.